Skip to Content

Tag: insulet


Also Noted

Insulet posts Q4 revenue increase, net loss

February 24, 2021HME News Staff

ACTON, Mass. – Insulet  reported revenues of $246.1 million for the fourth quarter of 2020, an increase of 17.5% over the same quarter in 2019. Full-year revenues were $904.4 million, an increase of 22.5% compared to the previous year. For the quarter, U.S. Omnipod revenue was $231.1 million and International Omnipod revenue was $149.2 million. Omnipod revenue for the full year was $834.9 million: $526.9 million in U.S. Omnipod...

diabetes, insulet, OmniPod


Read Full Articlered right arrow icon

News

In brief: Spiro Health grows, FDA warns, AAH comments

November 6, 2020HME News Staff

SANDWICH, Mass. - Spiro Health has acquired Absolute Respiratory Care in Johnston, R.I., further cementing its presence in New England and the Northeast.  Absolute Respiratory Care offers a full range of home medical equipment and supplies with a focus on sleep services. Through wireless monitoring, the provider has created a touchless telehealth model for sleep therapy.  “Absolute Respiratory Care is excited to join with the team at Spiro Health,” said Jayne Matoian,...

aahomecare, CareCentrix, insulet, NHIA, Numotion, Option Care, Spiro Health


Read Full Articlered right arrow icon

Also Noted

Insulet aims to increase diabetes awareness

November 5, 2020HME News Staff

ACTON, Mass. - Insulet Corp. has launched “YESvember,” a monthlong campaign to share inspiring stories of people living with diabetes on social media channels. The company is encouraging people to share how they are turning “no, I can't” into “yes, I can.” “We understand the many obstacles faced by people with diabetes and those who care for them,” said Shacey Petrovic, president and CEO. “Our innovative technology makes it possible for people...

diabetes, insulet, YESvember


Read Full Articlered right arrow icon

Also Noted

Insulet extends financial assistance to 'Podders'

April 17, 2020HME News Staff

ACTON, Mass. - Insulet, maker of the OmniPod system, has expanded its U.S. financial assistance program for current customers who have been negatively impacted by COVID-19. Upon meeting certain financial criteria, those customers may receive up to a six-month supply (60 pods). “Our coronavirus response plan is guided by our fundamental principles of protecting the health and safety of our employees, preserving the well-being of the communities in which we live and work, and ensuring that customers...

coronavirus outbreak, insulet, OmniPod


Read Full Articlered right arrow icon

Specialty Providers

Insulet reports year-over-year growth

February 27, 2020HME News Staff

ACTON, Mass. - Insulet Corp. reported revenue of $738.2 million for 2019, a 31% increase compared to 2018. The company reported full-year revenue of $673.5 million for the Omnipod, broken down by U.S. revenue of $420.2 million and international revenue of $253.1 million, a 30% and 47% increase, respectively.Insulet reported revenue of $209.4 million for the fourth quarter of 2019, a 27% increase compared to the same period in 2018. Operating income was $18.2 million."2019 was a remarkable year for...

diabetes, insulet, OmniPod


Read Full Articlered right arrow icon

News

In brief: Numotion acquires Monroe Wheelchair, AAH puts Walmart on notice

February 21, 2020HME News Staff

BRENTWOOD, Tenn. - Numotion has acquired Syracuse, N.Y.-based Monroe Wheelchair.Monroe has served as provider of complex rehab technology services for more than 75 years. It also offers augmentative and alternative communication (AAC) devices and software.“We are thrilled to announce that Monroe Wheelchair has been acquired by Numotion,” said Doug Westerdahl, CEO of Monroe. “Their customer-centric focus and employee-supportive organization align with our values and business principles....

aahomecare, dexcom, insulet, Monrose Wheelchair, Numotion, Rehab Medical


Read Full Articlered right arrow icon

Also Noted

Insulet identifies potential inaccuracy

February 14, 2020HME News Staff

ACTON, Mass. - Insulet has announced a voluntary medical device correction for its Omnipod DASH Personal Diabetes Managers. As part of an ongoing monitoring process, the company found that PDMs may suggest an inaccurate bolus amount based on a blood glucose value that is more than 10 minutes old when the user does not exit the bolus calculator as designed or when a system alarm interrupts a bolus calculation. No injuries have been reported and the Omnipod DASH is safe to use. All affected Omnipod...

insulet, Omnipod DASH Insulin Management System


Read Full Articlered right arrow icon

News

Financial results: Invacare on track, Insulet raises outlook

November 7, 2019HME News Staff

ELYRIA, Ohio - Invacare reported net sales of $235.8 million for the third quarter of 2019 compared to $244.6 million for the same period last year. Net loss was $8 million vs. $12 million. For North America HME, net sales decreased 1.8%, as slightly higher mobility and seating sales were more than offset by an 8.3% decline in respiratory sales and lower lifestyle product sales. Excluding respiratory, sales were up sequentially and essentially flat year over year. Invacare reported SG&A improved...

insulet, Invacare


Read Full Articlered right arrow icon

Specialty Providers

Insulet reports positive net income for first time

February 26, 2019HME News Staff

ACTON, Mass. - Insulet Corp. has reported net income of $9.9 million for the fourth quarter of 2018 compared to a net loss of $6.9 million for the same period in 2017.The company reported net income of $3.3 million for all of 2018 vs. a net loss of $26.8 million for 2017.It's the first time in Insulet's history that the company has achieved full-year positive operating income and net income.“Insulet had a remarkable 2018, achieving our third consecutive year of over 20% revenue growth, significantly...

financial results, insulet, OmniPod


Read Full Articlered right arrow icon

Also Noted

Insulet reduces net loss

August 3, 2018HME News Staff

BILLERICA, Mass. - Insulet Corp., maker of the Omnipod Insulin Management System, reported revenues of $124.3 million for the second quarter, a 13% increase compared to the same period last year. It reported revenues of $78.1 million for the Omnipod in the U.S., a 19% increase. Insulet reported a net loss of $1.7 million for the second quarter compared to a net loss of $7.8 million for the same period last year. Among the company's highlights in the second quarter: It assumed direct European operations...

financial results, insulet, insulin, OmniPod


Read Full Articlered right arrow icon